Ramipril: all 109 studies that test it
Page 2 of 2. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.
- Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 DiabetesCompletedNCT00240422Phase 4
- Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric PatientsCompletedNCT00221845Phase 3
- Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and DiabetesTerminatedNCT00208221Phase 3
- The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial DiseaseCompletedNCT00168467Phase 4
- The Study of Atherosclerosis With Ramipril and RosiglitazoneCompletedNCT00140647Phase 3
- The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) TrialCompletedNCT00095654Phase 3
- Irbesartan Versus Placebo in Combination With Ramipril for Treatment of AlbuminuriaCompletedNCT00095290Phase 4
- Treatment of Pediatric Hypertension With Altace TrialCompletedNCT00044265Phase 4
- Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel InflammationCompletedNCT00005928Phase 2